{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:41:57Z","timestamp":1770741717010,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>There are currently several diagnostic criteria for gestational diabetes (GDM). Both the WHO -2013 and NICE diagnose GDM based on a single step 75\u00a0g OGT; however; each uses different glucose thresholds. Previous studies have shown that the prevalence of GDM using the NICE criteria (GDM-N) is lower than that using the WHO-2013 criteria (GDM-W). Qatar has national diabetes in pregnancy program in which all pregnant women undergo OGTT screening using the WHO-2013 criteria. This study aims to define the prevalence of GDM using both criteria in a high-risk population. This retrospective study included 2000 women who underwent a 75\u00a0g (OGTT) between Jan 2016 and Apr 2016 and excluded patients with known pre-conception diabetes, multiple pregnancy, and those who did not complete the OGTT. We then classified the women into GDM-W positive, GDM-N positive but GDM-W negative, and normal glucose tolerance (NGT) population. A total of 1481 women (74%) had NGT using the NICE or the WHO-2013 criteria. The number of patients who met both criteria was 279 subjects (14%) with a good agreement (Kappa coefficient 0.67, p\u2009&lt;\u20090.001). The NICE and the WHO-2013 criteria were discordant in 240 subjects (12% of the cohort); 6.7% met the WHO -2013 criteria only and only 5.3% met the NICE criteria. The frequency of pre-eclampsia, pre-term delivery, Caesarean-section, LGA and neonatal ICU admissions were significantly increased in the GDM-W group. However, the GDM-N positive but GDM-W negative had no increased risk of maternal or fetal complications apart from pregnancy-induced hypertension. The WHO-2013 and the NICE criteria classified a similar proportion of pregnant women, 21.5% and 20.1%, respectively, as having GDM; however, they were concordant in only 14% of the cases. Women who are GDM-N positive but GDM-W negative are not at increased risk of maternal and fetal pregnancy complications, except for pregnancy-induced hypertension. As the NICE criteria are more specific to the UK population, we would recommend the use of the WHO-2013 criteria to diagnose GDM in the MENA region and possibly other regions that do not have the same set-up as the UK.\n<\/jats:p>","DOI":"10.1038\/s41598-021-84918-y","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T11:03:12Z","timestamp":1615374192000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Screening pregnant women in a high-risk population with WHO-2013 or NICE diagnostic criteria does not affect the prevalence of gestational diabetes"],"prefix":"10.1038","volume":"11","author":[{"given":"Mohammed","family":"Bashir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatin","family":"Eltaher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Beer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled","family":"Baagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Aboulfotouh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin C.","family":"Konje","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul-Badi","family":"Abou-Samra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,10]]},"reference":[{"key":"84918_CR1","unstructured":"WHO. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. 2013; http:\/\/apps.who.int\/iris\/bitstream\/10665\/85975\/1\/WHO_NMH_MND_13.2_eng.pdf"},{"key":"84918_CR2","doi-asserted-by":"crossref","unstructured":"ADA. 2. Classification and diagnosis of diabetes. Diabetes Care. 2014;38(Supplement_1):S8\u201316.","DOI":"10.2337\/dc15-S005"},{"issue":"11","key":"84918_CR3","doi-asserted-by":"publisher","first-page":"4227","DOI":"10.1210\/jc.2013-2465","volume":"98","author":"I Blumer","year":"2013","unstructured":"Blumer, I. et al. Diabetes and pregnancy: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 98(11), 4227\u20134249 (2013).","journal-title":"J Clin Endocrinol Metab."},{"key":"84918_CR4","unstructured":"Guidelines N. Diabetes in pregnancy. NICE Guid. 2015; https:\/\/www.nice.org.uk\/guidance\/ng3."},{"key":"84918_CR5","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S2213-8587(20)30189-3","volume":"8","author":"E Chiefari","year":"2020","unstructured":"Chiefari, E., Quaresima, P., Visconti, F., Mirabelli, M. & Brunetti, A. Gestational diabetes and fetal overgrowth: time to rethink screening guidelines. Lancet Diabetes Endocrinol. 8, 561\u2013562 (2020).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"84918_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/5393952","volume":"2020","author":"P Quaresima","year":"2020","unstructured":"Quaresima, P. et al. Appropriate timing of gestational diabetes mellitus diagnosis in medium- And low-risk women: Effectiveness of the Italian NHS recommendations in preventing fetal macrosomia. J Diabetes Res. 2020, 1\u20138 (2020).","journal-title":"J Diabetes Res."},{"key":"84918_CR7","doi-asserted-by":"crossref","unstructured":"Hyperglycemia and Adverse Pregnancy Outcomes (HAPO). 2008;1991\u20132002.","DOI":"10.1056\/NEJMoa0707943"},{"issue":"3","key":"84918_CR8","doi-asserted-by":"publisher","first-page":"676","DOI":"10.2337\/dc09-1848","volume":"33","author":"BE Metzger","year":"2010","unstructured":"Metzger, B. E. et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33(3), 676\u2013682 (2010).","journal-title":"Diabetes Care"},{"issue":"1","key":"84918_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/ajo.12394","volume":"56","author":"A Laafira","year":"2016","unstructured":"Laafira, A., White, S. W., Griffin, C. J. & Graham, D. Impact of the new IADPSG gestational diabetes diagnostic criteria on pregnancy outcomes in Western Australia. Aust New Zeal J Obstet Gynaecol. 56(1), 36\u201341 (2016).","journal-title":"Aust New Zeal J Obstet Gynaecol."},{"key":"84918_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ejogrb.2015.02.030","volume":"189","author":"BN Olagbuji","year":"2015","unstructured":"Olagbuji, B. N. et al. Prevalence of and risk factors for gestational diabetes using 1999, 2013 WHO and IADPSG criteria upon implementation of a universal one-step screening and diagnostic strategy in a sub-Saharan African population. Eur J Obstet Gynecol Reprod Biol. 189, 27\u201332 (2015).","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"84918_CR11","unstructured":"Al-Thani, Al Anoud., Bakri AH. Qatar Stepwise Report 2012 [Chronic Disease Risk Factor Surveillance]. 2012;1\u2013124. http:\/\/www.who.int\/chp\/steps\/Qatar_2012_STEPwise_Report.pdf."},{"key":"84918_CR12","unstructured":"Syed M. Clinical guidelines for the State of Qatar: the diagnosis and management of diabetes mellitus in pregnancy. 2019."},{"issue":"8","key":"84918_CR13","doi-asserted-by":"publisher","first-page":"e0201247","DOI":"10.1371\/journal.pone.0201247","volume":"13","author":"M Bashir","year":"2018","unstructured":"Bashir, M. et al. Prevalence of newly detected diabetes in pregnancy in Qatar, using universal screening. PLoS ONE 13(8), e0201247. https:\/\/doi.org\/10.1371\/journal.pone.0201247 (2018).","journal-title":"PLoS ONE"},{"issue":"3","key":"84918_CR14","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ijgo.2016.07.005","volume":"135","author":"J Djelmis","year":"2016","unstructured":"Djelmis, J. et al. Prevalence of gestational diabetes mellitus according to IADPSG and NICE criteria. Int J Gynecol Obstet. 135(3), 250\u2013254 (2016).","journal-title":"Int J Gynecol Obstet."},{"issue":"6","key":"84918_CR15","doi-asserted-by":"publisher","first-page":"523","DOI":"10.7196\/SAMJ.2017.v107i6.12043","volume":"107","author":"S Adam","year":"2017","unstructured":"Adam, S. & Rheeder, P. Screening for gestational diabetes mellitus in a South African population: Prevalence, comparison of diagnostic criteria and the role of risk factors. S Afr Med J. 107(6), 523 (2017).","journal-title":"S Afr Med J."},{"issue":"1","key":"84918_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00404-020-05564-9","volume":"302","author":"S Todi","year":"2020","unstructured":"Todi, S., Sagili, H. & Kamalanathan, S. K. Comparison of criteria of International Association of Diabetes and Pregnancy Study Groups (IADPSG) with National Institute for Health and Care Excellence (NICE) for diagnosis of gestational diabetes mellitus. Arch Gynecol Obstet. 302(1), 47\u201352. https:\/\/doi.org\/10.1007\/s00404-020-05564-9 (2020).","journal-title":"Arch Gynecol Obstet."},{"key":"84918_CR17","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2018.1550480","author":"M Bashir","year":"2018","unstructured":"Bashir, M. et al. Metformin-treated-GDM has lower risk of macrosomia compared to diet-treated GDM\u2014a retrospective cohort study. J Matern Fetal Neonatal Med. https:\/\/doi.org\/10.1080\/14767058.2018.1550480 (2018).","journal-title":"J Matern Fetal Neonatal Med."},{"key":"84918_CR18","doi-asserted-by":"publisher","first-page":"23612","DOI":"10.1136\/bmjopen-2018-023612","volume":"9","author":"M Bashir","year":"2019","unstructured":"Bashir, M. et al. Pregnancy outcomes of early detected gestational diabetes: a retrospective comparison cohort study, Qatar.  BMJ Open. 9, 23612 (2019).","journal-title":"BMJ Open."},{"key":"84918_CR19","unstructured":"Gynaecologists TAC of O and. Hypertension in Pregnancy. 2013; https:\/\/www.acog.org\/~\/media\/TaskForceandWorkGroupReports\/public\/HypertensioninPregnancy.pdf."},{"key":"84918_CR20","doi-asserted-by":"publisher","first-page":"107841","DOI":"10.1016\/j.diabres.2019.107841","volume":"157","author":"L Yuen","year":"2019","unstructured":"Yuen, L. et al. IDF Diabetes Atlas: projections of the prevalence of hyperglycaemia in pregnancy in 2019 and beyond: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 157, 107841. https:\/\/doi.org\/10.1016\/j.diabres.2019.107841 (2019).","journal-title":"Diabetes Res Clin Pract."},{"key":"84918_CR21","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2019.1583733","author":"CL Nguyen","year":"2019","unstructured":"Nguyen, C. L. et al. Prevalence and pregnancy outcomes of gestational diabetes mellitus by different international diagnostic criteria: a prospective cohort study in Vietnam. J Matern Neonatal Med. https:\/\/doi.org\/10.1080\/14767058.2019.1583733 (2019).","journal-title":"J Matern Neonatal Med."},{"key":"84918_CR22","doi-asserted-by":"publisher","first-page":"108144","DOI":"10.1016\/j.diabres.2020.108144","volume":"163","author":"EG O\u2019Malley","year":"2020","unstructured":"O\u2019Malley, E. G. et al. The diagnosis of gestational diabetes mellitus (GDM) using a 75 g oral glucose tolerance test: A prospective observational study. Diabetes Res Clin Pract. 163, 108144. https:\/\/doi.org\/10.1016\/j.diabres.2020.108144 (2020).","journal-title":"Diabetes Res Clin Pract."},{"issue":"3","key":"84918_CR23","doi-asserted-by":"publisher","first-page":"e0229496","DOI":"10.1371\/journal.pone.0229496","volume":"15","author":"S Koivunen","year":"2020","unstructured":"Koivunen, S. et al. Pregnancy outcomes according to the definition of gestational diabetes. PLoS ONE 15(3), e0229496 (2020).","journal-title":"PLoS ONE"},{"key":"84918_CR24","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/jcm7100376","volume":"7","author":"M Bhatia","year":"2018","unstructured":"Bhatia, M. et al. Clinical Implications of the NICE 2015 Criteria for Gestational Diabetes Mellitus. J Clin Med. 7, 376 (2018).","journal-title":"J Clin Med."},{"issue":"2","key":"84918_CR25","doi-asserted-by":"publisher","first-page":"144","DOI":"10.15537\/smj.2020.2.24842","volume":"41","author":"SA Alsaedi","year":"2020","unstructured":"Alsaedi, S. A., Altalhi, A. A., Nabrawi, M. F., Aldainy, A. A. & Wali, R. M. Prevalence and risk factors of gestational diabetes mellitus among pregnant patients visiting National Guard primary health care centers in Saudi Arabia. Saudi Med J. 41(2), 144\u2013150 (2020).","journal-title":"Saudi Med J."},{"issue":"3","key":"84918_CR26","doi-asserted-by":"publisher","first-page":"222","DOI":"10.5144\/0256-4947.2015.222","volume":"35","author":"EM Alfadhli","year":"2015","unstructured":"Alfadhli, E. M. et al. Gestational diabetes among Saudi women: prevalence, risk factors and pregnancy outcomes. Ann Saudi Med. 35(3), 222\u2013230 (2015).","journal-title":"Ann Saudi Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84918-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84918-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84918-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T05:02:59Z","timestamp":1670043779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84918-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,10]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["84918"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-84918-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,10]]},"assertion":[{"value":"21 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5604"}}